Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

The Ras Gene

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...

Small GTPases - Ras and Rho

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:

Therapeutic Index

Therapeutic Index

The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...

Therapeutic Communication

Therapeutic Communication

Communication is a lifelong learning process. Through therapeutic communication, nurses can collect relevant assessment data, provide education and counseling, and interact during nursing interventions. Sending and receiving messages occur through verbal and nonverbal communication techniques and can happen separately or simultaneously.
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...

Cholinergic Antagonists: Therapeutic Uses

Cholinergic Antagonists: Therapeutic Uses

Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Validated Tools to Evaluate Clinical Reasoning in Simulation-Based Learning: A Systematic Review for Physical Therapist Education.

Journal, physical therapy education·2026

Same author

Perceived challenges and solutions to providing rural physical therapy services: A qualitative inquiry of provider experience.

Physiotherapy theory and practice·2025

Same author

Amnestic Mild Cognitive Impairment Does Not Alter Cerebrocortical Oxygenation Dynamics During Acute Hypoxia-Reoxygenation in Older Adults.

Biomedicines·2025

Same author

Modeling response to the KRAS-G12C inhibitor AZD4625 in KRAS<sup>G12C</sup> NSCLC patient-derived xenografts reveals insights into primary resistance mechanisms.

British journal of cancer·2025

Same author

The multifunctional immune system.

Science (New York, N.Y.)·2025

Same author

Factors Associated With Diagnosing Psoriatic Arthritis: A Retrospective Study in Northeast Georgia.

The Permanente journal·2025

Search research articles

Related Experiment Video

Updated: Feb 6, 2026

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

Ras proteins as therapeutic targets.

Atanu Chakraborty¹, Emily Linnane¹, Sarah Ross²

¹Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, U.K.

Biochemical Society Transactions

|August 30, 2018

Summary

This summary is machine-generated.

Targeting Ras-driven cancers remains a significant challenge. Recent advances in small molecule drug design and novel therapeutic strategies offer new hope for developing effective treatments for Ras-related tumors.

Keywords:

RAS cancer drug therapy

More Related Videos

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

Related Experiment Videos

Last Updated: Feb 6, 2026

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

Area of Science:

Oncology
Drug Discovery
Molecular Biology

Background:

Mutations in RAS genes are a key driver in numerous human cancers.
Developing targeted therapies for Ras-driven cancers has been a long-standing challenge in oncology for over three decades.

Purpose of the Study:

To review the progress in Ras drug discovery.
To highlight recent advancements in directly targeting Ras proteins.
To discuss novel therapeutic strategies for Ras-driven malignancies.

Main Methods:

Literature review of Ras drug discovery efforts.
Analysis of recent developments in small molecule drug design targeting Ras.
Examination of novel therapeutic strategies for Ras-related cancers.

Main Results:

Significant progress has been made in understanding Ras biology and developing targeted agents.
Recent advances include innovative small molecule inhibitors and novel therapeutic approaches.
The review synthesizes key findings from extensive research in the field.

Conclusions:

Targeting Ras proteins directly presents a promising avenue for cancer therapy.
Continued research in small molecule design and novel strategies is crucial for effective Ras-driven cancer treatment.
These advancements offer renewed hope for patients with Ras-mutated tumors.